)
Edge6 Feb 2026
SharkNinja: Viral by Design
How SharkNinja built a repeatable growth engine, turning overlooked appliance categories into global brands through consumer insight and iteration.
ExpreS2ion Biotech
ExpreS2ion Biotech (EXPRS2) investor relations material
ExpreS2ion Biotech Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary19 Feb, 2026
Executive summary
Achieved significant clinical and strategic milestones in 2025, including progress in HER2 breast cancer immunotherapy, infectious disease programs, and advanced Phase I clinical trial for ES2B-C001 with positive safety and immunogenicity data.
Entered a licensing agreement with Serum Institute of India for malaria vaccine candidates RH5.1 and R78C, securing development and commercialization rights.
Progressed Nipah virus vaccine program with VICI-Disease consortium, selecting Northway Biotech as manufacturing partner and preparing clinical supply.
Multiple grant-funded programs expanded the pipeline with minimal capital burden, validating the ExpreS2 platform.
Strengthened financial position through successful warrant exercise, raising SEK 11.8 million before costs, and maintained focus on cost discipline and capital allocation.
Financial highlights
Q4 2025 total income was SEK 3.5 million, up 62% year-on-year; full year income reached SEK 12.2 million, a 56% increase from 2024.
Net sales for 2025 were SEK 3.7 million, up 21% year-on-year; grant income rose 78%.
Q4 operating costs were SEK 14 million, 37% lower than Q4 2024; personnel costs down 15% year-on-year.
Q4 net loss was SEK 8.2 million, a 46% improvement year-on-year; full year net loss SEK 38 million, 6% higher than 2024 due to a one-off gain in 2024.
Cash and equivalents at year-end were SEK 47.6 million, down 42% from prior year.
Outlook and guidance
Phase I-A data for ES2B-C001 expected mid-2026; Phase I-B data by year-end 2026.
Cash position of SEK 48 million as of December 31, 2025, supports advancement to next clinical milestones in 2026.
Cost base and cash outflow expected to remain consistent with recent quarters.
Ongoing evaluation of capital raising options, with a preference for non-dilutive funding.
Focus remains on generating high-quality clinical data and advancing partnered programs.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next ExpreS2ion Biotech earnings date
Q1 202619 May, 2026
ExpreS2ion Biotech
Next ExpreS2ion Biotech earnings date
Q1 202619 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
ExpreS2ion Biotech Holding AB (publ), through its subsidiary, ExpreS2 ion Biotechnologies ApS, develops, produces, and delivers therapeutics or diagnostic proteins in Denmark and internationally. The company uses its expression system technology to offer services that include cell line development, screening of cell bank clones developed in the clients' host cell line of interest, analytical services comprising host cell line development, clone screening and base media optimization, process scale-up and GMP manufacturing. It also manufactures and distributes therapeutic proteins based on prokaryotic and eukaryotic expression systems using the GalXC protein expression system to EU/US chemical and health companies.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage